Top

Published in:

Open Access 01-12-2011 | Poster presentation

Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD

Authors: AM Boldingh, EB Nordal

Published in: Pediatric Rheumatology | Special Issue 1/2011

Excerpt

There is a risk of developing serious complications of varicella zoster infection (VZI) in juvenile idiopathic arthritis (JIA) patients receiving disease modifying antirheumatic drugs (DMARD) including methotrexate and biologic agents [1, 2]. Varicella zoster (VZ) immune status should therefore be checked in all children before starting such therapy. Seronegative children mostly receive varicella zoster vaccine (VZV). Vaccination may prevent worried parents and reduce the need for VZ immunoglobulin, intravenous acyclovir treatment and hospitalization. …

Cerrasco R, Smith JA, Lovell D: Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs. 2004, 6 (3): 137-46. 10.2165/00148581-200406030-00001.CrossRef

Gluck T, Muller-Ladner U: Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 2008, 46: 1459-65. 10.1086/587063.CrossRefPubMed

Title: Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD
Authors: AM Boldingh
EB Nordal
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2011
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-9-S1-P132

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2011

Childhood morphea does not impair self-perception

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

The role of Inositol 1,4,5 triphosphate kinase C in the pathogenesis of Kawasaki disease

Adverse events of methotrexate treatment in JIA

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab